Intrauterine growth restriction (IUGR). Endocrine, nutritional and metabolic diseases complicating pregnancy
Conditions
Interventions
Intervention 1: Intervention group: (women who have not received magnesium supplements during the last 3 months) and are in the 14th week of pregnancy. They were randomly divided to receive placebo (p
Sponsors
Kashan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Pregnant woman at risk of IUGR
Exclusion criteria
Exclusion criteria: No history of underlying vascular disease history of IUGR baby birth
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Developmental responses. Timepoint: in 14-18 weeks and 34-28 weeks of pregnancy. Method of measurement: Comparison of uterine artery index.;Biomarkers of oxidative stress. Timepoint: in 14-18 weeks and 34-28 weeks of pregnancy. Method of measurement: Benzie and Strain method by calorimetric method using kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Inflammatory factors. Timepoint: 14-18 weeks and 34-28 weeks of pregnancy. Method of measurement: Using an ELISA device (immunoassay method).;Determination of lipid profiles. Timepoint: 14-18 weeks and 34-28 weeks of pregnancy. Method of measurement: Enzyme method using autoanalyzer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElaheh Mesdaghinia
Kashan University of Medical Sciences
Outcome results
None listed